Company: LNAI
Filing Date: 2025-07-18
Form Type: PRE 14A
Source: 0001731122-25-000995
Chunk: 25

Company: Lunai Bioworks Inc.
Filing Date: 2025-07-18
Form: PRE 14A
Chunk 25
---
 the Company before
the effectiveness of the Reverse Split Amendment, will require the affirmative vote of the holders of a majority of the votes cast by
stockholders entitled to vote on this proposal. Abstentions and broker non-votes will not be counted either for or against this proposal.
Approval of Proposal 1 by the Company’s stockholders includes approval that, at any time prior to the effectiveness of the filing
of the Reverse Split Amendment with the Secretary of State of the State of Delaware, notwithstanding authorization of the Reverse Split
Amendment by the Company’s stockholders, our Board may abandon the Reverse Split Amendment without further action by the Company’s
stockholders.

Board Recommendation

<div align='center'>OUR BOARD RECOMMENDS A VOTE “FOR” THE REVERSE SPLIT PROPOSAL.

15

PROPOSAL 2

THE ADJOURNMENT PROPOSAL</div>

Proposal

As described above, our Board
has recommended an amendment to our Certificate of Incorporation to effect a reverse split of our issued and outstanding shares of
common stock, at a specific ratio, ranging from one-for-three (1:3) to one-for-ten (1:10), with the exact ratio within such range to
be determined by our Board (Proposal 1). In furtherance of this recommendation, the Company is asking its stockholders to approve an
adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of
Proposal 1.

Vote Required

Proposal 2, to approve an
adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal
1, will require the affirmative vote of the holders of a majority of the votes cast by stockholders entitled to vote on this proposal.

Board Recommendation

<div align='center'>OUR BOARD RECOMMENDS A VOTE “FOR” THE ADJOURNMENT PROPOSAL.

16

SUMMARY</div>

This summary highlights
selected information from this proxy statement and may not contain all of the information that is important to you. To better understand
the Transaction and the other proposals being considered at the Special Meeting, you should read this entire proxy statement carefully,
including the materials attached as annexes, as well as other documents referred to or incorporated by reference herein. This proxy statement
also incorporates by reference certain information from the Renovaro 2024 Form 10-K and the Renovaro Third Quarter 202